Related references
Note: Only part of the references are listed.Overexpression of ErbB2 in the exocrine pancreas induces an inflammatory response but not increased proliferation
Hana Alguel et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Contribution of oncoproteomics to cancer biomarker discovery
William C. S. Cho
MOLECULAR CANCER (2007)
Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors
Pavel Pospisil et al.
CANCER RESEARCH (2007)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy
Kai Chen et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Mining expressed sequence tags identifies cancer markers of clinical interest
Fabien Campagne et al.
BMC BIOINFORMATICS (2006)
Novel blood biomarkers of human urinary bladder cancer
I Osman et al.
CLINICAL CANCER RESEARCH (2006)
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer
K Macleod et al.
CANCER RESEARCH (2005)
Multiclass cancer classification and biomarker discovery using GA-based algorithms
JJ Liu et al.
BIOINFORMATICS (2005)
Serum protein markers for early detection of ovarian cancer
G Mor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk
L Su et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
In biomarkers we trust?
M Baker
NATURE BIOTECHNOLOGY (2005)
Statistical analysis of global gene expression data: some practical considerations
T Holzman et al.
CURRENT OPINION IN BIOTECHNOLOGY (2004)
Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44
HR Kim et al.
CANCER RESEARCH (2004)
Detection of prostate cancer and predicting progression: Current and future diagnostic markers
JV Tricoli et al.
CLINICAL CANCER RESEARCH (2004)
Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis
DA Troyer et al.
DISEASE MARKERS (2004)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prognostic molecular markers in early breast cancer
FJ Esteva et al.
BREAST CANCER RESEARCH (2004)
Breast cancer biomarkers and molecular medicine
JS Ross et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2003)
Statistical significance for genomewide studies
JD Storey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis
Y Miyamoto et al.
CANCER CELL (2003)
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
JB Welsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The HER-2/neu gene and protein in breast cancer 2003: Biomarker and target of therapy
JS Ross et al.
ONCOLOGIST (2003)
Novel candidate tumor marker genes for lung adenocarcinoma
K Wang et al.
ONCOGENE (2002)
Matrix metalloproteinases and their role in pancreatic cancer: A review of preclinical studies and clinical trials
M Bloomston et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Expression profiling of microdissected pancreatic adenocarcinomas
T Crnogorac-Jurcevic et al.
ONCOGENE (2002)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation
S Sengupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?
W Zumkeller
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Share Paper
